Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3M Stock: It’s Not Just About the Masks or the Coronavirus

With 3M's N95 face masks flying off the shelves, the temporary bull case for MMM stock has some legs. But the raging coronavirus also underlines a potential, deep-seated shift in how we view 3M and similar organizations.

VZ Stock Will Eventually Be a Solid Buy

Few analysts will question the long-term viability of VZ stock. However, chasing this discount now may not be the best play, considering that worsening events suggest a better deal is coming.

LOW Stock Has Yet to Hit Its Lows

With panic-buying on the rise, LOW stock seemingly has some upside in the coronavirus. But it’s not turning out that way, giving investors a clear signal to wait for the volatility to subside.

Immediate Risks Weigh on Qualcomm Stock

Over the long run, it’s easy to have confidence in Qualcomm stock. But coronavirus from China has other plans and from a tactical view, we must respect it.

For Clorox Stock, the Coronavirus Is an Intriguing Catalyst

The present thesis for Clorox stock is an obvious one: people panic-buying disinfectants helps lifts CLX’s profile. Analysts regard this dynamic as a fleeting one but what if it’s not?